Membranous nephropathy in rheumatoid arthritis

Area of Science:

• Nephrology
• Rheumatology
• Clinical Pharmacology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease.
• Membranous nephropathy (MN) is a kidney disease characterized by thickening of the glomerular basement membrane.
• Nephrotic syndrome presents with edema, proteinuria, hypoalbuminemia, and hyperlipidemia.

Observation:

• A case study of a rheumatoid arthritis patient with nephrotic syndrome is presented.
• The patient's condition was not attributed to gold or penicillamine treatments.
• The nephrotic syndrome resolved completely after discontinuing hydroxychloroquine therapy.

Findings:

• Hydroxychloroquine therapy may be associated with the development of membranous nephropathy and nephrotic syndrome in rheumatoid arthritis patients.
• Discontinuation of hydroxychloroquine resulted in complete remission of nephrotic syndrome.
• This suggests a potential drug-induced nephrotoxicity.

Implications:

• Further research is warranted to investigate the incidence of subclinical membranous nephropathy in rheumatoid arthritis patients.
• The role of medications like hydroxychloroquine in triggering clinical kidney manifestations in RA needs further evaluation.
• This case highlights the importance of considering drug-induced nephropathy in rheumatoid arthritis patients presenting with nephrotic syndrome.